Perspective on OIG Guidelines for Pharmaceutical Companies: An Expert Interview With Arthur Palamara, MD
Laurie Barclay, MD Oct. 9, 2002 Editor’s Note: The Office of the Inspector General (OIG) is
Laurie Barclay, MD Oct. 9, 2002 Editor’s Note: The Office of the Inspector General (OIG) is
Laurie Barclay, MD Oct. 4, 2002 Editor’s Note: This week, the World Medical Association (WMA) convened
Valacyclovir treatment of infected genital herpes patients reduces the risk of transmission of the disease to an
NEW YORK (Reuters Health) Sept 25 – The results of a phase I trial show that recombinant
By Ori Twersky WASHINGTON (Reuters Health) Sept 25 – President Bush on Wednesday nominated Dr. Mark McClellan,
By Karen Pallarito NEW YORK (Reuters Health) Sept 25 – Academic institutions must establish policies for assuring
By Will Boggs, MD NEW YORK (Reuters Health) Sept 26 – A peptide derived from the transcription
British scientists have developed a method of measuring blood flow in human body tissue without the need
A traditional Indian folk remedy for treating psoriasis seems to have a biological basis, according to a
A unified, multidiscipline team approach to wound care may reduce the lower limb amputation rate among diabetics.
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות